GlobalLink’s Applanga solution shortens eCOA study ramp-up time and improves patient access to clinical trials worldwide

NEW YORK and PHILADELPHIA, October 31, 2022 /PRNewswire/ — TransPerfect, the world’s largest provider of language and technology solutions for global businesses, announced today that Clario has selected its GlobalLink Applanga technology to streamline translation processes.

Clario is a healthcare technology company that provides advanced endpoint technology solutions for decentralized (DCT), hybrid and on-site clinical trials. Clarios Translation Workbench is used to streamline the localization process, including managing multilingual content for licensed scales and data collection materials, as well as ensuring on-screen accuracy. Clario managed about 150 studies at a time, with each study covering an average of 20 languages ​​and eight assessments, and needed technology to give them automation to speed up the eCOA study initiation process.

GlobalLink Applanga is a cloud-based translation management system with features specifically designed for web-based applications, including mobile devices and clinical applications, enabling Clario to more effectively address application localization needs.

When connected to Applang through the API, Clario Translation Workbench initiates the localization process and simplifies the review and approval of screenshots. Screen capture is automated for each review, text capture and screenshot transfer with minimal effort.

As a result of implementing Applanga, Clario’s execution time was reduced by 30%. These reductions were achieved by reducing the time spent communicating between TransPerfect and Clario, eliminating the manual work required to create accurate screenshots and translations in eCOA programs, and minimizing defects and human error, reducing the burden on quality assurance staff.

“Our clients need to conduct research in multiple countries and provide patients with access to accurate and timely translations of their electronic clinical outcome assessments. Without it, pharma and biopharma customers face delays in getting new medicines to patients, and patients may not be able to provide important information about their health. With Clario’s global reach and TransPerfect technology, we can help improve patient access and reduce overall study preparation time,” he said. Terry BurkeEPP eCOA.

President and CEO of TransPerfect Phil Shaw noted, “Clario integrated Applanga in a way that allowed them to improve quality and efficiency. We are pleased that our technology has helped them reduce risk, lower costs and successfully fulfill their mission to bring treatments to market safely and quickly.”

About Clario

Clario is a leading technology company that creates the most comprehensive clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. With decentralized and web-based research, our deep scientific expertise, global reach and the broadest endpoint technology platform in the industry enable our partners to transform lives. Clario Trial Anywhere™ solutions have supported hybrid and decentralized clinical trials (DCTs) for more than 20 years, enabling sponsors to collect high-quality endpoint data from any modality, anywhere, while improving patient experience and diversity. Clario has a single technology platform that integrates eCOA, cardiac safety, medical imaging, precision motion and respiratory endpoints. With 30 facilities in nine countries, Clario’s global team of science, technology and operations experts has helped conduct more than 19,000 studies and secure 870 regulatory approvals for more than 5 m Patients in 120 countries. Our innovation has transformed clinical trials for 50 years.

About TransPerfect

TransPerfect is the world’s largest provider of language and technology solutions for global companies. From offices in more than 100 cities on six continents, TransPerfect offers its clients worldwide a full range of services in more than 200 languages. More than 6,000 organizations worldwide use TransPerfect GlobalLink® technology to simplify multilingual content management. With an unparalleled commitment to quality and customer service, TransPerfect is fully certified to ISO 9001 and ISO 17100. TransPerfect’s global headquarters are located in New Yorkwith the regional headquarters in London and Hong Kong. Visit our website at www.transperfect.com for more information.

SOURCE TransPerfect

Source link